Lymphoma, Non-HodgkinCancer
What this study is
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
Study details
- Sponsor
- Stanford University
- Conditions
- Lymphoma, Non-Hodgkin · Hodgkin's Disease
- Enrolling
- 9,999 people
- Starts
- 1999-01
- Est. completion
- 2099-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.
- Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).
- A routine procedure for tissue collection is planned.
- Ability to understand and the willingness to sign a written informed consent.
You can't join if
- Patients without NHL or Hodgkin's disease
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openStanford University School of Medicine
Stanford, California, United States
- Alyssa M Kanegai · Contact650-736-1596akanegai@stanford.edu
- Ronald Levy · Principal investigator
- Shoshana Levy · Sub-investigator
Recruiting
Study team
Sponsor
Stanford University
Study ID LYM0001
Principal investigator
Ronald Levy, MD
Stanford University
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.